|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 6 found articles
| Title: |
Steps towards medication harmonization: A look at Europe and the United States |
| Author: |
Cruz, Natalia Martin Barahona, Juan Hernangomez Sabate, Juan Manuel De La Fuente |
| Appeared in: |
Journal of comparative policy analysis |
| Paging: | Volume 8 (2006) nr. 3 pages 225-240 |
| Year: |
2006-09-01 |
| Contents: |
Countries with distinct institutional endowments are trying to reach drug harmonization. The explanation given for the beginning of this process is that the rising health concerns governments have about patients transcend their different visions of social welfare and increasing bureaucratic costs, for both pharmaceutical companies and governments. The underlying reasons are, on the one hand, the high transaction costs between the pharmaceutical companies and the patients of medication and, on the other hand, the differing pharmaceutical regulations increase bureaucratic costs. This situation pushed Europe, Japan and the US into initiating a process of harmonization of regulation for new drugs. Even though harmonization is an on-going process, global and simultaneous medication product approval is not easy (the final objective of harmonization). In this paper we present, from a transaction cost approach, the economic reasons why pharmaceutical transactions need to be under public control. At the same time, we evaluate the public policies related to pharmaceutical exchange - technical guidelines, funding and price policies - as elements of the institutional endowment of countries that could facilitate or slow down the harmonization process. We use two protagonists of the harmonization process: Europe and the United States. |
| Publisher: |
Routledge |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 6 found articles
| << previous | next >> |
Toegankelijkheidsverklaring